Oncology

ProvanAI Secures $1.2M to Develop Ovarian Cancer Risk Assessment

Vara Secures $8.9M to Expand AI Breast Cancer Detection Platform in Emerging Market

Largest Study on Scalp Cooling Published, Offering New Insights into Chemotherapy-Induced Hair Loss

PreciseDx Secures $20.7M to Advance AI-Powered Breast Cancer Risk Assessment Technology

Lunit Acquires Volpara to Enhance AI-Driven Breast Cancer Screening and Diagnostics

Lunit Targets US Market with $193M Acquisition of AI-Enabled Breast Cancer Detection Platform Volpara

Maia Oncology Secures $4.25M to Reinvent Cancer Care with an Initial Focus on Breast Cancer

New Study: Zai Lab’s ZEJULA Maintenance Therapy Shows Promising Results in Advanced Ovarian Cancer Patients

iSono Health Receives FDA Clearance for ATUSA, Its Automated and Wearable 3D Breast Ultrasound

Y Combinator Healthcare Partner Surbhi Sarna Joins Cancer Diagnostics Company AoA Dx as an Independent Board Member

Medtech Company Cooler Heads Adds $1.5M in New Funding After Receiving FDA Clearance to Help Save Cancer Patients’ Hair

Whiterabbit Partners with Solis Mammography to Increase Patient Compliance with Annual Check-ups

Therapixel Receives FDA Clearance for Use of Its AI-based Breast Cancer Screening Software MammoScreen on Digital Breast Tomosynthesis

Novarad and Ikonopedia Partner to Elevate Women’s Health in One Complete Mammography Platform

Bia Care Partners with GenesisCare to Support Women Experiencing Menopause as a Side Effect of Cancer Treatment

Israeli Femtech Company MobileODT Participates In India’s Largest Cervical Cancer Screening Program

New Survey: Women Are Skipping Cancer Screenings During the Pandemic, But Plan to get ‘Back on the Books’

Fujifilm and ScreenPoint Medical Now Offer Providers an AI Solution Designed for Early Breast Cancer Detection

AOA Dx Secures a Suite of IP Related To Early Detection in Support of its Mission to Transform Ovarian Cancer Diagnostics

Women’s Health Startup Mammogen Announces a $2M Seed Round and the Debut of its genTRU Liquid Biopsy Platform

AOA Dx Raises a $2.5 Million Seed Round to Develop the First Non-invasive Ovarian Cancer Liquid Biopsy Diagnostic Test 

#CervingConfidence: Grammy-winning Artist Ciara Partners with Hologic to Encourage Black Women to Get Checked for Cervical Cancer

Aspira Women’s Health Initiates Prospective Clinical Study for Benign Risk Monitoring and High Risk Early Ovarian Cancer Detection with Northwell Health

Roche Receives FDA Approval for the First Companion Diagnostic to Identify Endometrial Cancer Patients Eligible for Immunotherapy